公司概覽
業務類別 --
業務概覽 CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
公司地址 655 Elizabeth Street, Melbourne, VIC, AUS, 3000
電話號碼 +61 393891911
傳真號碼 +61 393891434
公司網頁 https://www.csl.com
員工數量 29000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Gordon Naylor, B.E.,C.P.A.,M.B.A. Director, Interim Chief Executive Officer and Managing Director -- 17/08/2026
 
董事會成員
董事會 職務 更新日期
Dr. Brian A. Mcnamee Chairman of the Board 17/08/2026
Dr. Brian Daniels, B.S.,M.D.,M.S. Independent Director 17/08/2026
Ms. Carolyn Hewson, BEc,M.A. Independent Director 17/08/2026
Mr. Costa Saroukos, B.Com Independent Director 17/08/2026
Ms. Elaine K. Sorg Independent Director 17/08/2026
Ms. Alison Mary Watkins, A.M.,B.Com Independent Director 17/08/2026
Professor Andrew Cuthbertson, A.O.,PhD Independent Director 17/08/2026
Ms. Samantha Lewis, B.A.,C.A. Independent Director 17/08/2026
Mr. Gordon Naylor, B.E.,C.P.A.,M.B.A. Director, Interim Chief Executive Officer and Managing Director 17/08/2026
Mr. Cameron Price, BEc,L.L.B. Independent Director 17/08/2026
 
所屬ETF (更新日期: 14/11/2026 02:55)
代號 名稱 佔比% ▼ 持有日期
DWMFWisdomTree International Mltfctr<0.000001%11/06/2026
EAFGPacer Developed Mkts Csh Cow Gr Ldr ETF<0.000001%21/09/2026
EFGiShares MSCI EAFE Growth ETF<0.000001%29/05/2026
ETGEV Tax Adv Global Dividend Inc<0.000001%30/06/2026
ETOEV Tax Adv Global Div Opps<0.000001%30/06/2026
EXGEV Tax-Mgd Gbl Div Equity Income<0.000001%30/06/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF<0.000001%27/02/2026
HAWXiShares Currency Hdgd MSCI ACWI exUS ETF<0.000001%06/03/2026
HEFAiShares Currency Hedged MSCI EAFE ETF<0.000001%03/03/2026
IFLOVictoryShares Intl Free Csh Flow ETF<0.000001%21/09/2026
IHDGWisdomTree Intl Hdgd Qual Div Gr ETF<0.000001%16/10/2026
INTFiShares International Equity Factor ETF<0.000001%04/03/2026
IQDGWisdomTree International Qual Div Gr ETF<0.000001%16/10/2026
IVSIApplied Finance IVS International LrgETF<0.000001%07/10/2026
JSTCAdasina Social Justice All Cp Glbl ETF<0.000001%01/06/2026
NUDMNuveen ESG Intl Dev Mkts Eq ETF<0.000001%01/06/2026
OEFAALPS O'Shares Intl Dev Qual Div ETF<0.000001%18/09/2026
PQNTPictet AI Enhanced International Eq ETF<0.000001%14/08/2026
QINTAmerican Century Quality Dvrs Intl ETF<0.000001%09/09/2026
RODMHartford Multifactor Dev Mkts (exUS) ETF<0.000001%13/03/2026
  1    2    3    4    5    6   7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.